Skip to main content

Advertisement

SpringerLink
Log in

Adenocarcinoma of the small intestine

  • Published:
Current Treatment Options in Gastroenterology Aims and scope Submit manuscript

Opinion statement

  • Adenocarcinomas of the small intestine are rare tumors accounting for about 1% of all gastrointesinal neoplasms.

  • These cancers have a poor prognosis, perhaps because of the nonspecific symptoms and delay in diagnosis.

  • They can arise in the setting of Crohn’s disease, celiac sprue, and inherited colon cancer syndromes like familial adenomatous polyposis (FAP).

  • As most of these lesions occur in the duodenum or proximal jejunum, upper endoscopy and push enteroscopy are reasonable initial diagnostic tests. Enteroclysis and intraoperative enteroscopy may be complementary to these procedures.

  • Surgical cures may be possible in patients with tumors detected at an early and resectable stage. Endoscopic therapy is useful for cure of premalignant lesions and palliation of unresectable disease.

  • Chemotherapy and radiotherapy have limited impact in the management of these tumors, because they are often of advanced stage at the time of presentation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Landis SH, Murray T, Bolden S, et al.: Cancer statistics, 1999. CA 1999, 49:8–31.

    Article  PubMed  CAS  Google Scholar 

  2. DiSario JA, Burt RW, Vargas H, et al.: Small bowel cancer: Epidemiological and clinical characteristics from a population-based registry. Am J Gastroenterol 1994, 89:699–701.

    PubMed  CAS  Google Scholar 

  3. Frost DB, Mercado PD: Small bowel cancers: A 30 year review. Ann Surg Oncol 1994, 1:290–295.

    Article  PubMed  CAS  Google Scholar 

  4. Neuget AI, Marvin MR: An Overview of adenocarcinoma of the small intestine. Oncology 1997, 11(4):529–536.

    Google Scholar 

  5. Ross RK, Hartnett NM, Bernstein L, et al.: Epidemiology of adenocarcinomas of the small intestine: Is bile a small bowel carcinogen? Br J Cancer 1991, 36:143–146.

    Google Scholar 

  6. Lowenfels AB: Does bile promote extracolonic cancers? Lancet 1996, 2:239–241.

    Google Scholar 

  7. Chen CC, Neuget AI, Rotterdam H: Risk factors for adenocarcinoma and malignant carcinoids of the small intestine: Preliminary findings. Cancer Epidemiol Biomarker, Prev 1994, 3:205–207.

    CAS  Google Scholar 

  8. Offerhaus GJA, Giardiello FM, Krush AJ, et al.: The risk of gastrointestinal cancers in familial adenomatous polyposis. Gastroenterology 1993, 102:1980–1982.

    Google Scholar 

  9. Nugent KP, Spigelman AD, Williams CB, et al.: Surveillance of duodenal polyps in familial adenomatous polyposis: progress report. J R Soc Med 1994, 87:704–706.

    PubMed  CAS  Google Scholar 

  10. Persson PG, Karlen P, Burnell O, et al.: Crohn’s disease and cancer: A population based cohort study. Gastroenterology 1994, 107:1675–1679.

    PubMed  CAS  Google Scholar 

  11. Bruno CJ, Kenneth B, Ahlquist D: Evidence against flat dysplasia as a regional field defect in small bowel adenocarcinoma associated with celiac disease. Mayo Clin Proc 1997, 72:320–322.

    Article  PubMed  CAS  Google Scholar 

  12. Arber N, Neugut AI, Weinstein IB, et al.: Molecular genetics of small bowel cancer. Cancer Epidemiol Biomarker Prev 1997, 6:745–748.

    CAS  Google Scholar 

  13. Tobi M, Kaila V, Hassan N, et al.: Monoclonal antibody Adnab-9 defines a preneoplastic marker in epithelium as risk for a adenocarcinoma of the small intestine. Hum Pathol 1999, 30(4):467–473.

    Article  PubMed  CAS  Google Scholar 

  14. Barnes JG, Romero L, Hess KR, et al.: Primary adenocarcinoma of the duodenum: Management and survival in 67 patients. Ann Surg Oncol 1994, 1:73–74.

    Article  PubMed  Google Scholar 

  15. Bauer RL, Palmer ML, Bauer Am, et al.: Adenocarcinoma of the small intestine: 21 year review of diagnosis, treatment and prognosis. Ann Sug Oncol 1994, 1(3):183–188. A retrospective study of 38 patients in whom surgical therapy performed before lymph node metastases improved the long term survival.

    Article  CAS  Google Scholar 

  16. MacKenzie J: Push enteroscopy. Gastrointest Endosc Clin N Am 1999, 1:29–36.

    Google Scholar 

  17. Seensalu R: Sonde examination. Gastrointest Endosc Clin N Am 1999, 1:37–59.

    Google Scholar 

  18. Oureil K, Adams JT: Adenocarcinoma of the small intestine. Am J Surg 1984, 147:66–71.

    Article  Google Scholar 

  19. Neuget AI, Jacobson JS, Suh S, et al.: The epidemiology of cancer of the small bowel. Cancer Epidemiol, Biomarker Prev 1998, 7:243–251. Excellent review on the epidemiology of adenocarcinomas of the small intestine.

    Google Scholar 

  20. Chow WH, Linet MS, Mclaughlin JK, et al.: Risk factors for small intestinal cancers. Cancer Causes Control 1993, 4:163–169.

    Article  PubMed  CAS  Google Scholar 

  21. Rose MD, Hochwald SN, Klimstar D, et al.: Primary duodenal adenocarcinoma: A ten year experience with 79 patients. J Am Coll Surg 1996, 183(2):89–86. A retrospective review of the largest number of patients from one center. Resectability and presence of distant metastatic disease were the strongest determinants of outcome in patients with duodenal adenocarcinoma.

    PubMed  CAS  Google Scholar 

  22. Laukka MA, Wang KK: Endoscopic Nd: YAG laser palliation of malignant duodenal tumors. Gastrointest Endosc 1995, 41:225–229. This study summarizes the outcome in 20 patients with malignant duodenal tumors. Palliation of gatrointestinal bleeding and obstruction was attempted to limit hospital admission and improve quality of life.

    Article  PubMed  CAS  Google Scholar 

  23. Hirasawa R, Iishi H, et al.: Clinicopathologic features and endoscopic resection of duodenal adenocarcinoma and adenomas with submucosal saline injection technique. Gastrointest Endosc 1997, 46:507–513. Endoscopic treatment was performed by injecting isotonic saline beneath the tumor in the submucosal layer, followed by polypectomy. No perforation or bleeding were experienced.

    Article  PubMed  CAS  Google Scholar 

  24. Binkert CA, Jost R, Steiner A, et al.: Benign and malignant stenoses of the stomach and duodenum: Treatment with self expanding metallic endoprostheses. Radiology 1996, 199(2):335–338. This case series describes technical success in 89% of patients using Wallstents. Over a mean period of 17 weeks of followup, quality of life improved in 78%.

    PubMed  CAS  Google Scholar 

  25. Kozarek RA, Brandabur JJ, Raltz SL, et al.: Expandable stents: Unusual locations. Am J Gastroenterol 1997, 92(5):812–814. Case series: successful stent placement in difficult areas of the small bowel. The median patient survival rate was 9 months.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Gastroenterology, University of Utah Medical Center, 50 N. Medical Drive, Room 4R118, 84132, Salt Lake City, UT, USA

    Anil Tumbapura MD

Authors
  1. Anil Tumbapura MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Scott Kuwada MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. James A. DiSario MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tumbapura, A., Kuwada, S. & DiSario, J.A. Adenocarcinoma of the small intestine. Curr Treat Options Gastro 3, 51–57 (2000). https://doi.org/10.1007/s11938-000-0061-4

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11938-000-0061-4

Keywords

Search

Navigation